MilliporeSigma | December 30, 2021
MilliporeSigma, the U.S. and Canada Life Science business of Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced that it has been awarded a $136.7M USD contract award for the construction of a lateral flow membrane production facility over a three-year period at the company's Sheboygan, Wisconsin site. The contract award from the U.S. Department of Defense (DoD), on behalf of the U.S. Department of Health and Human Services, is part of an effort to ensure secure local supply and production capacity for critical products for pandemic preparedness.
"With this agreement, MilliporeSigma will construct a state-of-the-art lateral flow membrane production facility that will give our in vitro diagnostic (IVD) manufacturing customers greater flexibility and security of supply of our Hi-Flow™ Plus lateral flow membranes."
Matthias Heinzel, Member of the Executive Board and CEO, Life Science, Merck KGaA, Darmstadt, Germany
"Our lateral flow membranes have earned a reputation for high consistency among rapid diagnostic manufacturers and the already robust demand for this membrane has significantly increased since the onset of the pandemic. With this critical investment, we are expanding much-needed access to essential diagnostic testing as a trusted partner to the world's most sophisticated diagnostic manufacturers," said Jean-Charles Wirth, head of Applied Solutions, Life Science.
Building this new facility supports the overall Life Science business sector's strategy to add physical capacity and expand its regional network to enable further growth of its key portfolios.
Hi-Flow™ Plus Lateral flow membrane is used in rapid diagnostic test kit manufacturing by the Life Science business' customers, enabling reproducible results due to its consistent quality and optimized properties. The rapid test kits are used for a variety of applications, including Infectious Disease testing (Covid-19, HIV, Influenza, Malaria, etc.), as well as in women's health, biomarker detection, drug testing, food safety and animal health. Due to continuously increasing demand for lateral flow membrane, the Life Science business had already invested in a second membrane casting line in Cork, Ireland, which was recently completed, and expanded the range of other critical reagents (antibodies, beads, blockers, buffers) utilized to develop lateral flow rapid test kits. These strategic investments position the Life Science business as an important critical raw material supplier for the Diagnostic market, especially as the company prepares for IVD Regulation and Medical Device Regulation.
The Life Science business is undertaking an ambitious, multi-year program to increase production capacity and capabilities to support the growing global demand for lifesaving vaccines, therapies and diagnostics. Within the last year, the company has accelerated investments to expand capacity to produce its support Mobius® single-use assemblies in both the U.S. and France, as well as increased capacity for the production of cell culture media in the U.S. and UK, among others. Additionally, several expansion projects continue to advance across the company's manufacturing and distribution global network.
About the Life Science business of Merck KGaA, Darmstadt, Germany
The Life Science business of Merck KGaA, Darmstadt, Germany, which operates as MilliporeSigma in the U.S. and Canada, has more than 23,000 employees and 59 manufacturing sites worldwide, with a portfolio of more than 300,000 products focused on scientific discovery, biomanufacturing and testing services. Merck KGaA, Darmstadt, Germany, a leading science and technology company, operates across healthcare, life science and electronics.
KBR | September 14, 2021
KBR has today announced a strategic partnership with Adarga, one of the UK's leading developers of artificial intelligence (AI) analytics software for defense and national security.
KBR's Government Solutions business will integrate Adarga's leading-edge AI software platform into the delivery of a number of its large-scale programs across the defense and national security sectors – putting effective, data-driven decision-making at the heart of how they operate.
The partnership will further extend KBR's capability offering across key market sectors and accelerate the speed and scale at which organizations can adopt next generation AI analytics to resolve their most complex data challenges. It will also allow clients to unlock vital insight, foresight and understanding of information buried across their ever-growing data sets.
This insight allows customers to improve retention of critical institutional knowledge, identify hidden connections to drive intelligence-led investigation, support strategic planning, and quantify future threats and opportunities. The addition of AI enhances and extends human capability by increasing agility, accuracy and productivity.
"This partnership is an exciting step to enhance our innovative and highly dependable solutions focused approach across key markets, with a shared ethos to help our customers resolve their most complex challenges," said Andrew Barrie, KBR President, Government Solutions EMEA.
Adarga's UK-developed Knowledge Platform™ is built for rapid integration with partner programs and is already providing vital insights for the UK Ministry of Defence by driving faster, better and more informed decisions.
Adarga CEO, Robert Bassett Cross, said, "Adarga is pleased to be partnering with KBR to expand the AI capabilities of customers across defense and national security. Together we will be able to provide customers with a transformational ability to leverage data as a strategic asset – a vital element of modern defense capability."
We deliver science, technology and engineering solutions to governments and companies around the world. KBR employs approximately 29,000 people worldwide with customers in more than 80 countries and operations in 40 countries.
KBR is proud to work with its customers across the globe to provide technology, value-added services, and long- term operations and maintenance services to ensure consistent delivery with predictable results. At KBR, We Deliver.
Databricks | July 15, 2020
Databricks, the data and AI company, today announced that Azure Databricks is now on Azure Government as a public preview. Databricks is used by organizations worldwide as an open platform for data engineering, machine learning and analytics. This preview complements Azure Databricks security and compliance for high-impact data analytics and AI across a wide range of use cases. From personalized healthcare and education to space exploration and energy research, Azure Databricks enables organizations to accelerate new innovation while minimizing risk.